Sinopsis
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episodios
-
![Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes]()
Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes
08/07/2019 Duración: 20minMaximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes
-
![The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma]()
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma
05/07/2019 Duración: 21minThe Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma
-
![Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies]()
Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies
10/06/2019 Duración: 16minOptimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies
-
![Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer]()
Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer
27/05/2019 Duración: 19minBeyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer
-
![Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy]()
Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy
17/05/2019 Duración: 28minAiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy
-
![Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions]()
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions
03/05/2019 Duración: 25minEmerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions
-
![Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer]()
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer
29/04/2019 Duración: 29minMerging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer
-
![Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression]()
Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression
15/03/2019 Duración: 21minOptimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression
-
![Managing Patients With HER2-Low Breast Cancer]()
Managing Patients With HER2-Low Breast Cancer
19/02/2019 Duración: 14minManaging Patients With HER2-Low Breast Cancer
-
![Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer]()
Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer
07/02/2019 Duración: 19minIs There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer
-
![Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy]()
Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy
26/11/2018 Duración: 01h14minBiomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy
-
![Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes]()
Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes
28/09/2018 Duración: 28minParoxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes
-
![Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma]()
Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma
20/09/2018 Duración: 19minBest Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma
-
![Best Practices in Managing CML]()
-
![Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer]()
Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer
04/07/2018 Duración: 19minClinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer
-
![Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer]()
Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
04/06/2018 Duración: 16minImproving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
-
![Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients]()
Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients
11/05/2018 Duración: 18minLocally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients
-
![Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco]()
Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco
09/05/2018 Duración: 08minImproving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco
-
![The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning]()
The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning
03/05/2018 Duración: 26minThe Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning
-
![Emerging Biomarkers in Small-Cell Lung Cancer: A New Era]()
Emerging Biomarkers in Small-Cell Lung Cancer: A New Era
30/04/2018 Duración: 16minEmerging Biomarkers in Small-Cell Lung Cancer: A New Era
